Dana Kappel

2PUBLICATIONS
27CO-AUTHORS
Molecular targetsComparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.

Melanie Royce, Mirat Shah, Lijun Zhang

|Jan 16, 2023
A Comparison of FDA and EMA Pregnancy and Lactation Labeling.

Dana Kappel, Leyla Sahin, Lynne Yao

Pageof 1